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Abstract
Although sleep is vital to all human functioning and poor sleep is a known
problem in cancer, it is unclear whether the overall prevalence of the various
types of sleep disorders in cancer is known. The purpose of this systematic liter-
ature review was to evaluate if the prevalence of sleep disorders could be ascer-
tained from the current body of literature regarding sleep in cancer. This was a
critical and systematic review of peer-reviewed, English-language, original arti-
cles published from 1980 through 15 October 2013, identified using electronic
search engines, a set of key words, and prespecified inclusion and exclusion cri-
teria. Information from 254 full-text, English-language articles was abstracted
onto a paper checklist by one reviewer, with a second reviewer randomly verify-
ing 50% (k = 99%). All abstracted data were entered into an electronic data-
base, verified for accuracy, and analyzed using descriptive statistics and
frequencies in SPSS (v.20) (North Castle, NY). Studies of sleep and cancer focus
on specific types of symptoms of poor sleep, and there are no published preva-
lence studies that focus on underlying sleep disorders. Challenging the current
paradigm of the way sleep is studied in cancer could produce better clinical
screening tools for use in oncology clinics leading to better triaging of patients
with sleep complaints to sleep specialists, and overall improvement in sleep
quality.
Introduction
Sleep is vital to all human functioning and encompasses a
complex set of physiological and behavioral processes;
disruption in one or more of these processes can lead to
many different types of symptoms of poor sleep that can
occur singly or in combination. In cancer patients, dis-
turbed sleep is rated the second most bothersome symp-
tom based on cancer and treatment status [1]. Sleep
problems are known to cause poor healing, increase
chances of cancer recurrence, decreased cognitive func-
tioning, decreased work productivity, increased safety
issues, medication misuse and abuse, poor relationships,
and increased health care costs [2–20].
Poor sleep is a known problem in cancer patients along
the treatment trajectory from the point of diagnosis to
end of life [21, 22]. In the United States in 2013, esti-
mates were that there are over 13.7 million people living
as cancer survivors, another 1.66 million will be diag-
nosed with cancer, and more than 580,000 will die of
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cancer. Poor sleep is known to affect up to 75% of these
individuals [23, 24]. Because of the importance of sleep
and the high prevalence of poor sleep in cancer, sleep-
related research, and symptom management have been
designated as research priorities by the Oncology Nursing
Society [25] and National Institute of Nursing Research
[26].
Poor sleep in cancer patients and survivors could be
attributed to the presence of one or more underlying
sleep disorders. Sleep disorders can be classified using two
main classification systems, the Diagnostic and Statistical
Manual of Mental Disorders-IV (DSM-IV) [27] or the
International Classification of Sleep Disorders (ICSD)
[28], and they can directly impact health-related quality
of life. Sleep disorders can occur singly or in combination
and include insomnia, sleep-related breathing disorders,
hypersomnia, circadian rhythm disorders, parasomnias,
sleep-related movement disorders, isolated symptoms, and
other nonspecified disorders [29]. Diagnosing specific
sleep disorders usually requires a detailed and specialized
evaluation, sometimes requiring overnight evaluation of
objective measures of sleep. However, it has been reported
that cancer patients often do not get referrals to sleep
specialists when presenting with chronic sleep complaints.
In a recent study of 78 patients with serious insomnia
complaints, only four (5%) received a recommendation
for formal follow-up or reassessment of the sleep problem
[20].
Details of specific sleep disorders should guide inter-
vention(s) since each type of sleep disorder may require a
different type of treatment. It is also pertinent to examine
how treatment of such sleep disorders fits within the
scope of practice for specialty clinics such as oncology.
However, the extent to which sleep disorders have been
studied in cancer is unclear, even though this information
is vital to appropriate assessment and intervention. There-
fore, the purpose of this systematic literature review was
to evaluate if the prevalence of various types of sleep dis-
orders could be ascertained from the current body of lit-
erature regarding sleep in cancer.
Methods
This was a critical and systematic review over a 2-year
time frame of peer-reviewed, English-language, original
articles published from 1980 through October 2013. We
used PubMed, PsychINFO, CINAHL, and OVID search
engines. Key words used for the search included; sleep,
sleep disturbances, sleep problems, insomnia, circadian
rhythm, restless leg syndrome, sleep apnea, narcolepsy,
daytime dysfunction, daytime sleepiness, cancer, breast
cancer. Breast cancer was specifically added as a search
term to capture the large body of literature from this
population on sleep. Limits were human, English lan-
guage, and adults. Articles were included if: (1) sleep was
identified as a primary outcome, a secondary outcome, or
a covariable of interest; and (2) articles were focused on
cancer diagnosis, treatment, survivorship, or end of life
(not prevention). Excluded were review articles, case stud-
ies, and abstracts.
Article titles and abstracts were reviewed and screened
for the following keywords; sleep, cancer, symptom clus-
ter, menopausal symptoms, correlates of sleep, narcolepsy,
circadian, restless leg syndrome, apnea, disturbance, and
daytime dysfunction. If the title seemed to fit review crite-
ria, the full-text article was pulled and read to determine
relevance to the review. If the article was deemed relevant,
information about the article was abstracted onto a paper
checklist. Once the final article list was identified, refer-
ences were checked against the available systematic
reviews in the literature to ensure all relevant articles were
captured. One reviewer completed data abstraction for all
selected articles. A second reviewer randomly checked
50% of the articles for data abstraction accuracy. A kappa
statistic was calculated and indicated good agreement
between the raters (k = 99%), confirming the accuracy of
the data abstraction. All abstracted data from the paper
checklists were entered into an electronic database. All
data entry was double checked for accuracy. Data were
analyzed using SPSS (v.20) (North Castle, NY). Descrip-
tive statistics and frequencies were obtained to synthesize
the major points of this review.
Results
The Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) [30] format was used as a
guide to develop a search diagram showing the flow for
the article retrieval process (Fig. 1). A total of 2620 article
titles were reviewed. This process resulted in identifying
339 full-text articles that were reviewed.
Of these, 254 articles met criteria to be included in this
review. The 254 articles were mainly from the United
States (n = 145, 57.5%) [3–7, 10–12, 14, 31–162], United
Kingdom/Europe (n = 43, 16.9%) [8, 163–186], and Can-
ada (n = 25, 9.8%) [16, 187–228]. Very few were pub-
lished during the 1980s (n = 4, 1.6%) [78, 82, 128, 135]
or 1990s (n = 16, 7.1%) [10, 14, 43, 46, 50, 56, 95, 104,
110, 115, 121, 189, 199, 208, 212, 229], with most pub-
lished in 2000 or later (n = 233, 91.3%) [3–8, 11, 12, 15,
16, 31–42, 44–49, 51–55, 57–75, 77, 79–81, 83–85, 87–94,
96–103, 105–109, 111–114, 116–120, 122–127, 129–134,
136–188, 190–198, 200–207, 209–211, 213–228, 230–269].
Quantitative descriptive studies were most common
(n = 186, 73.6%), [3–8, 11, 12, 14–16, 31, 32, 34, 37, 38,
40, 43–46, 48–50, 54–63, 67–76, 78, 80, 82, 84–101, 103–
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108, 110–116, 118–123, 126, 129, 130, 132, 133, 135–140,
142–146, 148, 150, 151, 154, 155, 158–160, 162, 163, 165,
168–171, 173–177, 181–185, 188, 191, 194–199, 202–209,
211, 213–215, 217–221, 223, 224, 227–233, 235, 237, 239–
243, 245–249, 251–255, 257, 259, 260, 263, 265–269] fol-
lowed by intervention studies (n = 58, 22.8%), [35, 36,
38, 39, 41, 42, 47, 51–53, 64, 65, 77, 81, 83, 102, 109, 113,
117, 124, 127, 128, 131, 134, 141, 147, 149, 153, 156, 157,
161, 164, 167, 172, 178–180, 186, 187, 189, 190, 193, 201,
210, 216, 222, 225, 226, 234, 238, 244, 250, 256, 258, 261,
262, 264] qualitative studies (n = 7, 2.8%) [66, 79, 152,
166, 192, 200, 212], and mixed-methods studies (n = 2,
0.8%) [10, 33].
Description of studies
Study samples primarily included patients with a mix of
different types of cancers (n = 104, 40.9%) [3, 4, 8, 10,
14, 35, 36, 45, 47, 48, 50, 52, 58, 62, 66, 68, 69, 72, 75,
78, 80–82, 84, 88, 89, 93, 95, 98–100, 103–105, 111, 113,
115–117, 120–122, 127–130, 143, 145, 149, 161, 162, 164–
170, 174, 181, 182, 184, 187, 189–192, 194–196, 198, 203,
206, 208, 212, 215, 216, 218, 221, 223, 224, 227–229, 231,
232, 234, 236, 238, 240–243, 245, 247, 248, 253, 254, 259,
261, 264, 266–268] or patients with breast cancer
(n = 102, 40.2%), [5–7, 11, 12, 15, 16, 31, 32, 34, 37–44,
46, 49, 51, 55–57, 59, 61, 63–65, 73, 76, 77, 79, 83, 85–87,
91, 92, 94, 96, 97, 101, 102, 106, 108, 112, 118, 119, 123–
126, 131, 132, 134, 136–141, 148, 151, 154–160, 163, 172,
173, 175, 176, 178–180, 183, 186, 188, 193, 200–202, 210,
214, 220, 222, 225, 226, 230, 233, 239, 249–251, 256, 263,
265] with fewer studies focused on another single cancer
diagnosis (n = 48, 18.9%) [33, 38, 53, 54, 67, 70, 71, 74,
107, 109, 110, 114, 133, 135, 142, 144, 146, 147, 150, 152,
153, 171, 185, 197, 199, 204, 205, 207, 209, 211, 213, 217,
219, 235, 237, 244, 246, 252, 255, 257, 258, 260, 262,
269]. Of the latter, studies focusing on lung cancer were
most common (n = 14) [70, 71, 74, 109, 110, 135, 144,
152, 197, 204, 205, 235, 246, 257]. The total number of
participants with cancer appeared as high as 3343,
Titles screen and eliminated as duplicates
(n = 661)
Titles eliminated
(non-cancer, sleep not the primary
variable of interest, risk/prevention study,
case study/editorial)
(n = 1,385)
Titles identified 
(n = 1706) key word cancer
(n = 851) keyword breast cancer
N = 2,557
Titles screened
(n = 1,896)
Abstracts reviewed
(n = 511)
Full-text articles assessed for eligibility
(n = 339)
Full-text articles meeting eligibility criteria and
included in final analysis
(n = 254)
Full-text articles excluded
(non-cancer, sleep  not the primary or
secondary variable of interest,
risk/prevention study, case
study/editorial)
(n = 85)
Abstracts excluded
(non-cancer, sleep  not the primary
variable of interest, risk/prevention study,
case study/editorial)
(n = 172)
Figure 1. PRISMA diagram for sleep review.
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although there was duplication where data were reported
in more than one manuscript. The number of participants
in the control groups (including cancer and noncancer)
evaluated in studies was 1607. Only 90 studies (35%) [3,
7, 11, 34–36, 38, 39, 43, 46, 48, 50–53, 58, 63–65, 69–71,
74, 77, 78, 85, 93–95, 101, 102, 106, 109, 113, 115, 117,
122, 125, 128, 129, 132–135, 137, 141, 145–147, 149, 153–
157, 161, 163, 178, 179, 187, 188, 190, 191, 193, 194, 204,
214–217, 219, 224, 225, 229, 234, 236, 237, 240, 244, 245,
247, 250, 255, 256, 258, 261, 262, 264] included a com-
parison group in the study design, with most comparison
groups being subjects with cancer.
Sleep-specific characteristics of studies
Methodological characteristics of the 254 articles are
shown in Table 1. The time points for assessing sleep
were varied but mainly focus on accessing sleep problems
during and postcancer treatment. Most articles reviewed
focused on sleep as a concurrently occurring or clustered
variable with either fatigue or one or more other symp-
toms (59%). [3, 5–7, 12, 14–16, 32, 33, 35, 37–49, 51–54,
56–62, 67–69, 71, 73–77, 79–86, 88, 89, 92, 93, 96, 97,
101, 102, 104–108, 110–114, 116, 118, 122, 124–127, 129–
131, 133, 134, 136–150, 154–160, 162–164, 167–170, 173,
178, 179, 183, 185, 188, 191, 193, 195, 198, 200–203, 207,
208, 212, 214–216, 218, 220–230, 234, 241, 243–245, 247,
248, 250–254, 256–259, 261, 263–269].
When selecting participants for studies, potentially
important inclusion and exclusion criteria for sleep were
rarely addressed. For example, only 19.7% (n = 50) [35–
41, 48, 49, 61, 63, 69, 77, 87, 90, 91, 99, 108, 109, 115,
122, 129, 136, 138, 140, 141, 151, 160, 161, 163, 172–174,
178–181, 187, 189, 192, 204, 217, 221, 233–235, 255, 266]
of the studies reviewed excluded for previous sleep disor-
der or current treatment of sleep disorders.
The majority of studies did not include a definition of
sleep or sleep problems, did not classify sleep disorders,
and did not discuss the etiology of the sleep problems
studied. Only 26 (10.2%) [8, 36, 40, 58, 64, 65, 77, 97,
98, 108, 109, 115, 161, 172, 173, 176, 178, 179, 182, 190,
192, 209, 210, 216, 231, 240] studies used a formal diag-
nostic classification system within the study design. Thir-
teen of these 26 studies used the DSM-IV (n = 13) [36,
65, 97, 108, 109, 161, 176, 190, 192, 210, 216, 231, 240].
The remaining 13 articles used a combination of the
DSM and ICSD (n = 8), ICSD alone (n = 4), or a classifi-
cation used by the American Society of Dentist Anesthesi-
ologists (n = 1). Those using diagnostic classification
systems used them as a mechanism to verify eligibility for
studies specifically looking for primary insomnia. No
other specific details from these studies were provided
Table 1. Methodological characteristics of reviewed articles.
Characteristic
N (%)
n = 254
Type of cancer
Mixed 104 (40.9)
Breast 102 (40.2)
Other 48 (18.9)
Time point
Pretreatment 25 (9.8)
During treatment 76 (29.9)
Posttreatment 72 (28.3)
Palliative care 17 (6.7)
Mixed 49 (19.3)
Type of study design
Descriptive 187 (73.6)
Intervention 58 (22.8)
Qualitative 7 (2.8)
Mixed methods 2 (0.8)
Priority of sleep
Primary alone 83 (32.7)
Concurrent with fatigue 23 (9.1)
Concurrent with cluster 147 (57.9)
Sleep term defined
Yes 50 (19.7)
No 204 (80.3)
Formal classifications of sleep disorders used
Yes 26 (10.2)
No 228 (89.8)
Etiology of sleep problem provided
Yes 64 (25.2)
No 190 (74.8)
Subjective measure of sleep
PSQI 81 (31.9)
Single item from standardized form 46 (18.1)
No subjective measure 28 (11.0)
Other 99 (39.0)
Objective measure of sleep
Actigraphy 5 (20.9)
Polysomnography 16 (6.3)
None 185 (72.8)
Included biomarkers of sleep
Yes 18 (7.1)
No 236 (92.9)
Assessed medication use (prescription and over-the-counter)
Yes 64 (25.2)
No 190 (74.8)
Body mass index reported
Yes 44 (17.3)
No 213 (82.7)
Noncancer comorbidities reported
Yes 41 (16.1)
No 213 (83.9)
Discipline of author(s)
Nursing 62 (24.4)
Mixed 99 (39.0)
Medicine 48 (18.8)
Psychology 25 (9.8)
Other or not listed 20 (8.0)
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such as frequency of other possible sleep findings that
could be used to establish some prevalence information.
In addition, sleep was primarily assessed using self-
report and not objective measures. The most common
standardized measure used was the Pittsburgh Sleep Qual-
ity Index (n = 81), a valid and reliable instrument. The
most common approach was a single item or multiple
items from a larger standardized or investigator-generated
questionnaire. For objective measures, wrist actigraphy
was the most common approach, with polysomnography
only used in 16 studies. Wrist actigraphy is typically used
more often due to the expense of polysomnography,
which often requires an overnight stay in a hospital or
clinic for evaluation.
Few studies reported assessing biomarkers such as ferri-
tin, which plays a role in the etiology of restless leg syn-
drome. In addition, few studies reported concurrent
medication use, particularly medications that could help
or hinder sleep. Finally, few studies reported body mass
index (important to diagnosing the potential for sleep
apnea) or noncancer comorbidities that could hinder
sleep. Potentially important exclusion criteria such as
poor performance status, psychiatric illnesses, cognitive
impairment, and anemia were also often not reported or
not used.
Interventions were a part of only 33, or 13%, of the
total studies reviewed. The most common interventions
tested were formal or investigator-generated behavioral
treatments for insomnia. Other interventions included
mostly nonpharmacotherapy interventions such as acu-
puncture, yoga, relaxation, and exercise. Only five studies
tested pharmacotherapy for treatment. The efficacy of
these interventions for cancer patients has been assessed
and can be found on the Oncology Nursing Society Putt-
ing Evidence into Practice website (www.ons.org).
Discussion
The major conclusion of this review is that the prevalence
of overall particular types of sleep disorders in cancer
cannot be ascertained using currently available literature.
This is true across studies using mixed cancer samples
and larger studies that focus specifically on populations of
breast and lung cancer patients and survivors.
The main reason we cannot ascertain prevalence of spe-
cific sleep disorders relates to the conceptualization and
operationalization of poor sleep. Our review indicates that
studies have focused on measuring general symptoms of
poor sleep rather than on the underlying sleep disorders.
Symptoms of poor sleep include a decreased number of
hours of sleep (sleep duration), increased number of min-
utes to fall asleep (sleep latency), nighttime awakenings
(sleep disruptions), and inability to function fully during
the day without naps (daytime dysfunction) [14, 270].
These symptoms are consistent with insomnia and can
occur singly or in combination, affecting overall sleep
quality and daytime function [271–274]. These symptoms
help to define poor sleep but are common to more than
one sleep disorder [21]. In the reviewed literature, we
found that the terminology for symptoms of poor sleep is
often used interchangeably with that for specific sleep dis-
orders which therefore are not fully assessed.
This imprecise conceptualization of sleep has led to
narrowly focused interventions being diffusely targeted to
symptoms, rather than focused and specific to one or
more sleep disorders underlying those symptoms.
Although some interventions for sleep in cancer have
shown possible efficacy [25], the majority of these studies
are too targeted to undefined subtypes of insomnia and
therefore are not generalizable to the many patients who
may have other types of sleep disorders [113, 178]. This
makes translating these interventions into oncology prac-
tice difficult.
To ascertain prevalence of the various types of disor-
ders, we must change the current method for studying
sleep in persons with cancer, which has focused on using
single- or multi-item scales to assess and classify symp-
toms of poor sleep [17, 21, 275]. A total of 33 different
subjective sleep measures were used across studies, with
little consistency among those measures although the
Pittsburgh Sleep Quality Index, used in 32% of the stud-
ies, was the most common. These measures neglect the
larger issue of assessing specific types of sleep disorders
underlying symptoms (e.g., trouble falling asleep and
Table 1. Continued.
Characteristic
N (%)
n = 254
Country of origin of authors
United States of America 146 (57.5)
United Kingdom/Europe 43 (16.9)
Canada 25 (9.8)
Year published
1982–1989 4 (1.6)
1990–1999 18 (7.1)
2000–2013 232 (91.3)
Discipline of author(s)
Nursing 62 (24.4)
Mixed 99 (39.0)
Medicine 48 (18.8)
Interventions studied
N (%)
n = 54
Cognitive-behavioral therapy 23 (42.6)
Pharmacologic 6 (11.1)
Other 25 (46.3)
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staying asleep, nighttime disturbances) that are common
to several different sleep disorders. Particular types of
sleep disorders require different interventions, yet most
intervention studies target undefined subtypes of insom-
nia as a single, underlying sleep disorder. This is problem-
atic because there are 11 different subtypes of insomnia
and not all are responsive to the same intervention [28].
Based on reports from clinical practice, patients can
experience more than one type of sleep disorder concur-
rently, which influences how sleep is treated. For example,
one seminal study found that 40% of breast cancer survi-
vors had symptoms suggestive of both insomnia (unde-
clared subtypes) and a sleep-related movement disorder
(e.g., restless leg syndrome) [8]. In addition, although sleep
apnea has long been assumed to be relatively uncommon in
women (<9%), one study of midlife women without cancer
who reported symptoms of poor sleep found that 53% met
criteria for sleep apnea [276]. This supports the finding that
postmenopausal women have sleep apnea at the same prev-
alence rate as men [277]. These findings also suggest that
the next logical step in sleep research for cancer patients is
to correctly identify the prevalence of distinct types of sleep
disorders in patients reporting symptoms of poor sleep so
that appropriate clinical assessment tools and interventions
can be developed and tested by oncology and general
health-care providers. Perhaps this type of clinical assess-
ment could be started in relation to one type of cancer such
as in breast cancer patients and then translated to other
cancer diagnoses or other chronic illnesses for testing.
Limitations of this review
Conclusions from this systematic review should be tem-
pered in light of some limitations. First, our review focused
on English-language articles, which may have excluded
some important information about sleep disorders in can-
cer. Second, although every attempt was made to identify
all pertinent articles, it is possible that some were missed,
which also might have affected our conclusions.
Implications for practice
Sleep disorder prevalence data would be helpful for future
intervention development. One place to begin is deter-
mining how symptoms are being addressed in the clinic
visit. The role of oncology health practitioners in delin-
eating complaints of sleep problems remains a challenge.
With several formal practice guidelines available, the real-
ity of clinic visits is that addressing symptoms is deter-
mined by a multitude of variables. During treatment
there are sometimes other cancer-specific symptoms that
are obvious contributing factors to acute sleep problems.
For example, patients with end-stage lung cancer often
have breathing problems that mimic sleep apnea or meta-
static pain that is not controlled, and in this context
pharmacological approaches may be appropriate. How-
ever, if such obvious problems are not present during
survivorship it is unclear if oncology practitioners have
the appropriate assessment tools to decide whether to
make referrals to sleep specialists who could formally
diagnose sleep disorders. Although practice guidelines can
provide a global understanding of how to treat a patient
with sleep complaints, future interventions for sleep need
to involve educating about and implementing the use of
short assessment tools for oncology patients and their
providers as a basis for more effective treatments in the
clinic setting and/or appropriate referrals for further test-
ing. An assessment tool would need to be brief and target
the common sleep disorders such as restless leg syndrome,
sleep apnea, and possibly narcolepsy (although less fre-
quently found in the general population). This tool would
need to be sensitive enough to warrant appropriate refer-
ral to sleep medicine specialists for further diagnostic
evaluation. Integrating into practice could be in the form
of a screening tool that integrates into the electronic med-
ical record to reflect current clinic practices. Future inter-
ventions should also be translatable to smaller
community settings where specialized oncology clinics are
not readily available.
For research there are several considerations moving
forward. Revising common inclusion and exclusion crite-
ria used in research studies is required to better reflect
the complexity of sleep. Although specific inclusion and
exclusion criteria for studies is largely dependent on the
type of research question(s) being addressed, specific
questions that identify possible symptoms of common
sleep disorders for both descriptive and intervention
research would better reflect the influence the fact that
people tend to have more than one type of sleep problem.
For behavioral intervention work this is especially crucial
because having undiagnosed sleep disorders can have a
negative impact on the efficacy findings of those studies.
In addition, refining current measurements of sleep that
better assist in detangling the common sleep complaint is
required. Specifically, screening all research subjects using
a brief screening form for sleep disorders would better
identify the prevalence of specific sleep disorders across
the cancer trajectory. Providing this type of information
would better inform if different questionnaires were
needed based on the type of cancer being studied based
on the prevalence in that population.
Conclusion
Although the literature, especially in the past 10 years,
has raised awareness that poor sleep is problematic
6 ª 2014 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Review of Sleep in Cancer J. L. Otte et al.
throughout the cancer trajectory, the prevalence of partic-
ular types of sleep disorders in cancer remains unclear.
This is likely due to the primary focus on studying symp-
toms of poor sleep and not characterizing the underlying
sleep disorders in cancer patients and survivors. This
review indicates that little is known about the prevalence
of specific sleep disorders in cancer, which hampers the
ability to fully understand (1) how to triage clinical
assessments of sleep complaints by all levels and types of
health-care practitioners that have contact with cancer
patients and survivors and (2) how best to intervene for
patients presenting in specialty clinics such as oncology
with sleep complaints. Future studies should challenge the
current research paradigm that focuses on describing and
intervening narrowly on symptoms of poor sleep. Sleep
screenings are needed that are tailored to facilitate better
triage, referral for further assessment when appropriate,
and more effective interventions that take into account
the multiple types of sleep disorders.
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